Source: ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Katherine J. Baines, Thomas K. Wright, Peter G. Gibson, Heather Powell, Philip M. Hansbro, Jodie L. Simpson. Azithromycin treatment modifies airway and blood gene expression networks in neutrophilic COPD. ERJ Open Res, 4 (4) 00031-2018; 10.1183/23120541.00031-2018

Member's Comments

No comment yet.

Related content which might interest you: Relationship between blood eosinophil count and bronchial epithelial gene expression in COPD versus Asthma Source: International Congress 2018 – Eosinophils in airway disease Year: 2018 A sputum gene expression signature predicts oral corticosteroid response in asthma Source: Eur Respir J, 49 (6) 1700180; 10.1183/13993003.00180-2017 Year: 2017 Variation in the TLR4 gene and airway inflammation among patients with COPD Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Treatment: how does inflammatory phenotype influence response to treatment in airway disease? Source: Annual Congress 2007 - Inflammatory phenotypes in airway disease Year: 2007 Association of sputum chitinase like protein levels with pathophysiology and neutrophilic airway inflammation in asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 The expression of CD39 mRNA is altered in peripheral blood of patients with allergic asthma Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 Airway inflammation in COPD: physiological outcome measures and induced sputum Source: Eur Respir J 2003; 21: 19S-28S Year: 2003 Effects of salmeterol/fluticasone propionate (SFC) on airway inflammation in induced sputum in COPD Source: Annual Congress 2005 - Effects of anti-inflammatory drugs on COPD Year: 2005 Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Chronic sputum production in COPD is a marker for airway inflammation and colonisation Source: Eur Respir J 2004; 24: Suppl. 48, 306s Year: 2004 Photobiomodulation and corticosteroid modulate pulmonary inflammation and airway reactivity in an experimental model of chronic asthma Source: International Congress 2018 – Basic pharmacology Year: 2018 Increased numbers of alveolar mast cells with an altered phenotype are linked to peripheral airway remodelling in patients with allergic asthma Source: Annual Congress 2012 - Mechanisms of asthma Year: 2012 Effect of COPD exacerbations on early lung function decline under maintenance therapy: blood eosinophil count asbiomarker Source: International Congress 2019 – Eosinophils and FeNO in airway diseases Year: 2019 Association between bacterial load and inflammatory gene expression in COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 The lung microbiota changes associated with inhaled corticosteroid and azithromycin in murine model of COPD Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation Source: Eur Respir J 2002; 20: Suppl. 38, 142s Year: 2002 COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012 Meta-analysis of airway epithelium gene expression in asthma Source: Eur Respir J, 51 (5) 1701962; 10.1183/13993003.01962-2017 Year: 2018 Same role and same treatment for airway eosinophilia in asthma and COPD? Source: Eur Respir J 2007; 29: 831-833 Year: 2007 Chronic sputum production and airway inflammation in COPD in the stable state and at exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 442s Year: 2005